Z
9.75
0.18 (1.88%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Mixed |
| Biotechnology (Global) | Mixed | Mixed | |
| Stock | Zenas BioPharma, Inc. | - | - |
AIStockmoo Score
1.6
| Analyst Consensus | 4.0 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -0.5 |
| Average | 1.63 |
|
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcγRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| % Held by Insiders | 24.78% |
| % Held by Institutions | 65.08% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Sr One Capital Management, Lp | 30 Sep 2024 | 4,911,539 |
| Nvp Associates, Llc | 30 Sep 2024 | 1,838,482 |
| Novo Holdings A/S | 30 Sep 2024 | 1,150,000 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 45.00 (Guggenheim, 361.54%) | Buy |
| Median | 35.00 (258.97%) | |
| Low | 27.00 (Citigroup, 176.92%) | Buy |
| Average | 34.40 (252.82%) | |
| Total | 5 Buy | |
| Avg. Price @ Call | 14.20 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| HC Wainwright & Co. | 16 Dec 2024 | 30.00 (207.69%) | Buy | 8.77 |
| Morgan Stanley | 11 Dec 2024 | 35.00 (258.97%) | Buy | 9.16 |
| 08 Oct 2024 | 40.00 (310.26%) | Buy | 17.69 | |
| Citigroup | 08 Oct 2024 | 27.00 (176.92%) | Buy | 17.69 |
| Guggenheim | 08 Oct 2024 | 45.00 (361.54%) | Buy | 17.69 |
| Jefferies | 08 Oct 2024 | 35.00 (258.97%) | Buy | 17.69 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |